Synonyms: GSK-2636771
Compound class:
Synthetic organic
Comment: GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, with anticancer effects in PTEN null cells [2].
|
|
Bioactivity Comments |
GSK2636771 significantly decreases cell viability in PI3Kβ-reliant PTEN-deficient PC3 prostate and BT549 and HCC70 breast cancer cell lines [3]. It weakly inhibits proliferation of mouse MLg2908 lung fibroblasts (IC50 >20 μM) [1]. We have been unable to find peer-reviewed publicly available data which confirms the action of this compound at its proposed primary molecular target. |